[Symptomatic treatment of acute inflammation of the upper respiratory airways in pediatrics].
D000082:Acetaminophen / Q000627:therapeutic use; D000208:Acute Disease; D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D011298:Feprazone / Q000627:therapeutic use*; D006140:Guaifenesin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D010653:Phenylbutazone / Q000031:analogs & derivatives*; D011817:Rabbits; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013488:Suppositories
D000700:Analgesics; D004338:Drug Combinations; D013488:Suppositories; D000082:Acetaminophen; D006140:Guaifenesin; D011298:Feprazone; D010653:Phenylbutazone
Trattamento sintomatico delle infiammazioni acute delle prime vie aeree (IAPVA) in pediatria